Skip to main content

Market Overview

Illumina Falls 20% After Preliminary Q1 Results 'Fell Short Of Expectations'

Share:

Shares of Illumina, Inc. (NASDAQ: ILMN) plunged nearly 20 percent Tuesday morning after the company reported disappointing preliminary first quarter results on Monday.

Illumina said it expects to record revenue of $572 million in the first quarter. Even though the company's guidance represents a 6 percent increase year-over-year, it fell short of the $$596.33 million Wall Street analysts were expecting.

Illumina will report its first quarter results on May 3 and will provide an updated earnings per share guidance at that time.

"Our first quarter results fell short of expectations largely due to lower than expected sales of HiSeq 2500, 3000 and 4000 instruments. Despite this slow start in Q1, we anticipate that our Americas and Asia Pacific regions will meet our expectations for the full year, but that Europe will underperform. As a result, we now project approximately 12% revenue growth for fiscal 2016," stated Jay Flatley, Chairman and CEO. "Given the disappointing outlook in Europe, we have made management changes in the region and plan to implement a program of actions to achieve our goal of delivering the robust growth we believe the market can support."

A conference call to discuss the company's preliminary results was held on Monday and can be accessed through the company's investor relations website.

 

Related Articles (ILMN)

View Comments and Join the Discussion!

Posted-In: Genetic Analysis Illuminia Jay FlatleyNews Guidance

Need corporate guidance data?
Click here to see licensing options.
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com